BTG3 and hepatocellular carcinoma: In conclusion, our study showed that miR-106b-5p, as an oncogenic miRNA, was overexpressed in HCC and could promote the proliferation, metastasis, and drug resistance of HCC through activating the BTG3/Bcl-xL/p27 signaling pathway.